Your browser doesn't support javascript.
loading
Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea / Journal of the Korean Cancer Association, 대한암학회지
Article in English | WPRIM (Western Pacific) | ID: wpr-47263
Responsible library: WPRO
ABSTRACT

PURPOSE:

This study was conducted in order to determine the most cost-effective strategy, in terms of interval and age range, for liver cancer screening in the high-risk population of Korea. MATERIALS AND

METHODS:

A stochastic model was used to simulate the cost-effectiveness of liver cancer screening by combined ultrasonography and alpha-fetoprotein testing when varying both screening intervals and age ranges. The effectiveness of these screening strategies in the high-risk population was defined as the probability of detecting preclinical liver cancer, and cost was based on the direct cost of the screening and confirmative tests. Optimal cost-effectiveness was determined using the incremental cost-effectiveness ratio.

RESULTS:

Among the 36 alternative strategies, one-year or two-year interval screening for men aged between 50 and 80 years, six-month or one-year interval screening for men aged between 40 and 80 years, and six-month interval screening for men aged between 30 and 80 years were identified as non-dominated strategies. For women, identified non-dominated strategies were one-year interval screening between age 50 and 65 years, one-year or six-month interval screening between age 50 and 80 years, six-month interval screening between age 40 and 80 years, and six-month interval screening between age 30 and 80 years.

CONCLUSION:

In Korea, a one-year screening interval for men aged 50 to 80 years would be marginally cost-effective. Further studies should be conducted in order to evaluate effectiveness of liver cancer screening, and compare the cost effectiveness of different liver cancer screening programs with a final outcome indicator such as quality-adjusted life-years or disability-adjusted life-years.
Subject(s)

Full text: Available Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 4: Health financing / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: WPRIM (Western Pacific) Main subject: Alpha-Fetoproteins / Mass Screening / Ultrasonography / Cost-Benefit Analysis / Republic of Korea / Korea / Liver Neoplasms Type of study: Diagnostic study / Etiology study / Health economic evaluation / Screening study Aspects: Patient-preference Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Cancer Research and Treatment Year: 2014 Document type: Article
Full text: Available Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 4: Health financing / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: WPRIM (Western Pacific) Main subject: Alpha-Fetoproteins / Mass Screening / Ultrasonography / Cost-Benefit Analysis / Republic of Korea / Korea / Liver Neoplasms Type of study: Diagnostic study / Etiology study / Health economic evaluation / Screening study Aspects: Patient-preference Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: English Journal: Cancer Research and Treatment Year: 2014 Document type: Article
...